Stock listing
Frankfurt:KB7 Solventum Corporation Aktie
German listing (Frankfurt) of Solventum Corporation · home listing NYSE:SOLV
Follow Solventum Corporation into a list and get an email when it puts out news.
Share price · FWB:KB7
€77.20 EUR -0.20 (-0.3%)
Close on Nov 20, 2026
- Day range
- €76.80 – €77.20 EURNov 20, 2026
- Market cap
- €13.14B EURAt the close on Nov 20, 2026 · price × 170.2M shares outstanding
- 52-week range
- €53.53 – €81.79 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €7,127 EURMedian day 25 shares · 11 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:SOLV · Home | $84.50 USD | -1.98 (-2.3%) | 658,351 | $86.41 | $87.11 | $84.13 | $86.48 | Close on Nov 20, 2026 |
| Frankfurt:KB7 | €77.20 EUR | -0.20 (-0.3%) | — | €76.80 | €77.20 | €76.80 | €77.40 | Close on Nov 20, 2026 |
| Stuttgart:KB7 | €76.80 EUR | -1.20 (-1.5%) | — | €77.40 | €78.80 | €76.80 | €78.00 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:KB7 · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €81.39 | +4.827 | +6.3% | €76.26 | €81.79 | €76.13 | 25 | |
| €76.57 | -2.039 | -2.6% | €78.77 | €79.47 | €76.06 | 542 | |
| €78.61 | +3.76 | +5.0% | €74.38 | €80.48 | €74.18 | 542 | |
| €74.85 | -0.292 | -0.4% | €73.88 | €74.97 | €73.49 | 5 | |
| €75.14 | +1.589 | +2.2% | €72.50 | €75.90 | €71.35 | 0 | |
| €73.55 | -0.391 | -0.5% | €73.55 | €73.55 | €73.55 | 30 | |
| €73.94 | +0.459 | +0.6% | €73.23 | €73.96 | €72.91 | 180 | |
| €73.48 | -0.996 | -1.3% | €73.48 | €73.48 | €73.48 | 2 | |
| €74.48 | -0.409 | -0.5% | €75.49 | €75.63 | €74.06 | 0 | |
| €74.89 | -1.781 | -2.3% | €76.09 | €76.16 | €74.81 | 390 | |
| €76.67 | +1.273 | +1.7% | €76.44 | €77.40 | €76.42 | 324 | |
| €75.39 | -0.272 | -0.4% | €75.39 | €75.39 | €75.39 | 360 | |
| €75.67 | -0.776 | -1.0% | €76.07 | €76.75 | €75.53 | 16 | |
| €76.44 | +0.229 | +0.3% | €74.97 | €77.12 | €74.14 | 15 | |
| €76.21 | -1.513 | -1.9% | €75.44 | €76.23 | €75.23 | 25 | |
| €77.73 | +0.056 | +0.1% | €77.93 | €77.99 | €77.33 | 0 | |
| €77.67 | +1.807 | +2.4% | €77.46 | €77.91 | €76.47 | 114 | |
| €75.86 | +0.261 | +0.3% | €75.86 | €75.86 | €75.86 | 0 | |
| €75.60 | -1.899 | -2.5% | €75.60 | €75.60 | €75.60 | 0 | |
| €77.50 | +1.234 | +1.6% | €77.61 | €77.61 | €77.09 | 97 | |
| €76.27 | +0.151 | +0.2% | €76.52 | €76.55 | €76.27 | 336 | |
| €76.12 | -0.79 | -1.0% | €76.00 | €76.95 | €74.47 | 10 | |
| €76.91 | -0.038 | 0.0% | €76.85 | €77.53 | €76.70 | 25 | |
| €76.94 | +0.022 | 0.0% | €77.05 | €77.05 | €76.86 | 27 | |
| €76.92 | +0.318 | +0.4% | €76.92 | €76.92 | €76.92 | 6 | |
| €76.60 | -0.534 | -0.7% | €77.60 | €77.90 | €76.59 | 76 | |
| €77.14 | -0.959 | -1.2% | €77.36 | €77.36 | €76.45 | 20 | |
| €78.10 | +0.691 | +0.9% | €78.10 | €78.10 | €78.10 | 0 | |
| €77.41 | +0.802 | +1.0% | €77.41 | €77.41 | €77.41 | 0 | |
| €76.60 | -0.644 | -0.8% | €76.60 | €76.60 | €76.60 | 0 | |
| €77.25 | +0.786 | +1.0% | €76.87 | €77.40 | €76.85 | 20 | |
| €76.46 | -0.681 | -0.9% | €76.46 | €76.46 | €76.46 | 52 | |
| €77.14 | +0.43 | +0.6% | €77.13 | €77.31 | €76.10 | 0 | |
| €76.71 | +0.575 | +0.8% | €75.73 | €77.19 | €75.66 | 35 | |
| €76.14 | -0.47 | -0.6% | €76.14 | €76.14 | €76.10 | 210 | |
| €76.61 | -0.495 | -0.6% | €75.60 | €77.28 | €75.35 | 60 | |
| €77.10 | -1.927 | -2.4% | €77.10 | €77.10 | €77.10 | 0 | |
| €79.03 | +1.405 | +1.8% | €77.41 | €79.15 | €77.23 | 28 | |
| €77.62 | +1.673 | +2.2% | €77.27 | €77.67 | €76.40 | 4 | |
| €75.95 | +0.545 | +0.7% | €74.52 | €76.01 | €74.17 | 145 | |
| €75.41 | -0.825 | -1.1% | €75.41 | €75.41 | €75.41 | 228 | |
| €76.23 | +0.005 | 0.0% | €76.63 | €76.71 | €75.08 | 233 | |
| €76.23 | -1.572 | -2.0% | €76.49 | €76.67 | €76.23 | 12 | |
| €77.80 | -0.488 | -0.6% | €78.20 | €78.24 | €77.34 | 2 | |
| €78.29 | +0.227 | +0.3% | €77.82 | €79.26 | €77.71 | 285 | |
| €78.06 | +0.106 | +0.1% | €78.06 | €78.06 | €78.06 | 60 | |
| €77.95 | +0.874 | +1.1% | €78.15 | €78.90 | €77.46 | 16 | |
| €77.08 | -1.74 | -2.2% | €77.08 | €77.08 | €77.08 | 12 | |
| €78.82 | +1.197 | +1.5% | €77.78 | €79.91 | €76.79 | 187 | |
| €77.62 | +0.415 | +0.5% | €77.62 | €77.62 | €77.62 | 3 | |
| €77.21 | +0.362 | +0.5% | €77.21 | €77.21 | €77.21 | 215 | |
| €76.85 | -0.924 | -1.2% | €76.85 | €76.85 | €76.85 | 0 | |
| €77.77 | +1.382 | +1.8% | €77.77 | €77.77 | €77.77 | 11 | |
| €76.39 | +0.002 | 0.0% | €76.39 | €76.39 | €76.39 | 50 | |
| €76.39 | +1.40 | +1.9% | €74.94 | €76.84 | €74.54 | 204 | |
| €74.99 | -0.652 | -0.9% | €74.81 | €75.40 | €74.27 | 31 | |
| €75.64 | +1.478 | +2.0% | €74.84 | €76.11 | €74.00 | 31 |
- Ticker
- Frankfurt:KB7
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 5, 2026
Solventum Reports Third Quarter 2026 Financial Results
Latest earnings call · Nov 5, 2026
Solventum (NYSE:SOLV) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 5, 2026
Q3 2026 Earnings Presentation
Earnings · 15 slides
Latest news
Solventum Reports Third Quarter 2026 Financial Results
Nov 5, 2026
Closed €81.39 (+6.3%) on Nov 6, 2026
Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*
Oct 19, 2026
Closed €76.44 (+0.3%) on Oct 20, 2026
Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026
Oct 15, 2026
Closed €77.73 (+0.1%) on Oct 16, 2026
Solventum to Participate in the 2026 Wells Fargo Healthcare Conference
Sep 2, 2026
Closed €77.95 (+1.1%) on Sep 3, 2026
Solventum Reports Second Quarter 2026 Financial Results
Aug 5, 2026
Closed €72.62 (-3.0%) on Aug 6, 2026
Solventum Announces Intent to Separate its Health Information Systems Business
Aug 5, 2026
Closed €72.62 (-3.0%) on Aug 6, 2026
Solventum to Report Second Quarter Fiscal 2026 Earnings on August 5, 2026
Jul 15, 2026
Closed €69.92 (+3.8%) on Jul 16, 2026
Solventum to Participate in the 2026 Jefferies Healthcare Conference
May 27, 2026
Closed €65.62 (+1.4%) on May 28, 2026
Solventum to Participate in the 2026 BofA Securities Health Care Conference
May 7, 2026
Closed €60.14 (-0.8%) on May 8, 2026
Solventum Reports First Quarter 2026 Financial Results
May 5, 2026
Closed €59.06 (+4.4%) on May 6, 2026
Solventum Corporation on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 18 in the last 12 months · 44 in all · newest Nov 5, 2026 · oldest 2025
- Calls
- 10 calls with a replay · 10 with a transcript · latest Nov 5, 2026
- Decks
- 16 decks · latest Nov 5, 2026
Where Solventum Corporation is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:SOLV · Home listing | NYSE | United States | USD |
| gettex:KB7 | gettex | Germany | EUR |
| LS Exchange:A407ZE | LS Exchange | Germany | EUR |
| Tradegate:KB7 | Tradegate | Germany | EUR |
| BMV:SOLV | BMV | Mexico | MXN |
| Lang & Schwarz:A407ZE | Lang & Schwarz | Germany | EUR |
| Dusseldorf:KB7 | Dusseldorf | Germany | EUR |
| BIVA:SOLV | BIVA | Mexico | MXN |
| BOATS:SOLV | BOATS | United States | USD |
| Frankfurt:KB7 · This page | Frankfurt | Germany | EUR |
| BX Swiss:SOLV | BX Swiss | Switzerland | CHF |
| LSE:0AD1 | LSE | United Kingdom | USD |
| Milan:1SOLV | Milan | Italy | EUR |
| Hamburg:KB7 | Hamburg | Germany | EUR |
| Munich:KB7 | Munich | Germany | EUR |
| Stuttgart:KB7 | Stuttgart | Germany | EUR |
Valuation
P/E 92.1× against a median of 33.4×: the highest of 10 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $18.98B USD
- P/E
- 92.1×
- EV/sales
- 2.3×
- EV/EBITDA
- 20.0×
- Price/book
- 3.0×
- Gross margin
- 54.8%
- Operating margin
- 5.6%
- Net margin
- 1.9%
- Debt to equity
- 1.1×
- Beta vs S&P 500
- 0.56
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Solventum Corporation · NYSE:SOLV | US$14.36B | US$18.98B | 92.1× | 2.3× | 20.0× | 3.0× | 1.9% | 1.1× | 0.56 |
| Straumann Holding AG · SIX:STMN | US$20.27B | US$20.39B | 47.8× | 6.6× | 24.6× | 7.5× | 13.7% | 0.2× | n/a |
| Zimmer Biomet Holdings, Inc. · NYSE:ZBH | US$19.13B | US$26.24B | 24.9× | 3.1× | 11.6× | 1.5× | 8.9% | 0.6× | 0.40 |
| Coloplast A/S Class B · OMXCOP:COLO_B | US$15.08B | US$18.16B | 33.4× | 4.3× | 10.5× | 7.2× | 10.6% | 1.5× | n/a |
| Shanghai United Imaging Healthcare Co., Ltd. Class A · SSE:688271 | US$14.48B | US$13.77B | 54.1× | 5.9× | n/a | 4.4× | 11.5% | 0.1× | n/a |
| Baxter International Inc. · NYSE:BAX | US$13.14B | US$12.00B | n/a | 1.0× | 16.2× | 2.0× | −6.2% | 0.1× | 0.97 |
| Penumbra, Inc. · NYSE:PEN | US$12.58B | US$11.90B | 80.1× | 7.6× | n/a | 7.9× | 10.1% | 0.0× | 0.18 |
| Smith & Nephew plc · LSE:SN. | US$12.54B | US$15.58B | 20.1× | 2.5× | 11.4× | 2.4× | 10.1% | 0.7× | n/a |
| The Cooper Companies, Inc. · NASDAQ:COO | US$11.20B | US$13.59B | 19.6× | 3.2× | 14.6× | 1.3× | 13.5% | 0.3× | 0.50 |
| Align Technology, Inc. · NASDAQ:ALGN | US$11.02B | US$9.88B | 22.4× | 2.4× | 11.5× | 2.6× | 11.8% | 0.0× | 1.26 |
| Demant A/S · OMXCOP:DEMANT | US$10.68B | US$13.44B | 47.1× | 4.0× | 17.1× | 6.5× | 6.7% | 1.8× | n/a |
| Median of the others | US$12.86B | US$13.68B | 33.4× | 3.6× | 13.1× | 3.5× | 10.4% | 0.3× | 0.50 |
Forecasts
7 strong buy · 1 buy · 5 hold · 1 sell · 1 strong sell · Analysts' consensus from EODHD, read Nov 22, 2026. Not 6ix's view and not investment advice.
- Price target
- 98.38 USD · Analysts' mean
- EPS, year to Dec 2026
- 7.26 · 13 analysts
- Revenue, year to Dec 2026
- 8.25B · 13 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Bryan Hanson | Chief Executive Officer |
| Wayde McMillan | Chief Financial Officer |
| Marcela Kirberger | Chief Corporate and Legal Affairs Officer and Corporate Secretary |
| Mike Spears | Senior Vice President, Regulatory Affairs & Quality Assurance |
| Amy Landucci | Chief Information & Digital Officer |
| Heather Knight | Chief Commercial Officer |
| Kathy Weiler | Chief Transformation and Enterprise Services Officer |
| Ken Tripp | Chief Supply Chain Officer |
| Paul Harrington | Chief Supply Chain Officer |
| Rachel Ellingson | Chief Strategy & Corporate Development Officer |
| Tammy Gomez | Chief Human Resources Officer |
Board
| Director | Role |
|---|---|
| Marcela Kirberger | Chief Corporate and Legal Affairs Officer and Corporate Secretary |
Events
Calls
| Call | When | Status |
|---|---|---|
| Solventum (NYSE:SOLV) Q3 2026 Earnings Call | Thu, Nov 05, 2026 · 4:30 PM ET | Replay |
| Solventum (NYSE:SOLV) Q2 2026 Earnings Call | Wed, Aug 05, 2026 · 4:30 PM ET | Replay |
| Solventum (NYSE:SOLV) Q1 2026 Earnings Call | Tue, May 05, 2026 · 4:30 PM ET | Replay |
| Solventum (NYSE:SOLV) Q4 2025 Earnings Call | Thu, Feb 26, 2026 · 4:30 PM ET | Replay |
| Solventum (NYSE:SOLV) Q3 2025 Earnings Call | Thu, Nov 06, 2025 · 4:30 PM ET | Replay |
| Solventum (NYSE:SOLV) Q2 2025 Earnings Call | Thu, Aug 07, 2025 · 4:30 PM ET | Replay |
| Solventum (NYSE:SOLV) Q1 2025 Earnings Call | Thu, May 08, 2025 · 4:30 PM ET | Replay |
| Solventum (NYSE:SOLV) Q4 2024 Earnings Call | Thu, Feb 27, 2025 · 4:30 PM ET | Replay |
| Solventum (NYSE:SOLV) Q3 2024 Earnings Call | Thu, Nov 07, 2024 · 4:30 PM ET | Replay |
| Solventum (NYSE:SOLV) Q2 2024 Earnings Call | Thu, Aug 08, 2024 · 4:30 PM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 5, 2026 · After close | +3.7% |
| Q2 2026 | Aug 5, 2026 · After close | −5.2% |
| Q1 2026 | May 5, 2026 · After close | +2.8% |
| Q4 2025 | Feb 26, 2026 | −1.2% |
| Q3 2025 | Nov 6, 2025 · After close | +7.9% |
| Q2 2025 | Aug 7, 2025 · After close | +2.0% |
| Q1 2025 | May 8, 2025 · After close | +5.4% |
| Q4 2024 | Feb 27, 2025 | −5.1% |
| Q3 2024 | Nov 7, 2024 · After close | −3.5% |
| Q2 2024 | Aug 8, 2024 · After close | +3.3% |
All 12 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 9, 2024 · Before open | −2.4% |
| Q4 2023 | Feb 28, 2024 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 15 slides | Nov 5, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 15 slides | Aug 5, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 15 slides | May 5, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 17 slides | Feb 26, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 15 slides | Nov 6, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 14 slides | Aug 7, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 13 slides | May 8, 2025 |
| Fact Sheet (2025) | Fact sheet | 1 slide | Mar 21, 2025 |
| Investor Day (March 2025) | Investor day | 98 slides | Mar 20, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 15 slides | Feb 27, 2025 |
All 16 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2024 Earnings Presentation | Earnings | 13 slides | Nov 7, 2024 |
| Q2 2024 Earnings Presentation | Earnings | 13 slides | Aug 8, 2024 |
| Q1 2024 Earnings Presentation | Earnings | 15 slides | May 9, 2024 |
| Investor Day (March 2024) | Investor day | 59 slides | Mar 19, 2024 |
| Investor Presentation (2024) | Investor deck | 21 slides | 2024 |
| Fact Sheet (2023) | Fact sheet | 1 slide | 2023 |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 8.32B | 8.25B | 8.20B | 8.13B | 8.17B | 7.28B |
| Cost of revenue | 3.87B | 3.66B | 3.50B | 3.44B | 3.25B | 2.97B |
| Gross profit | 4.45B | 4.59B | 4.69B | 4.70B | 4.92B | 4.32B |
| Research and development | 739.0M | 775.0M | 758.0M | 767.0M | 766.0M | 719.0M |
| Selling, general and administrative | 3.08B | 2.78B | 2.30B | 2.23B | 2.28B | 2.17B |
| Operating income | 2.18B | 1.04B | 1.69B | 1.69B | 1.88B | 1.43B |
| Depreciation and amortization | 489.0M | 555.0M | 561.0M | 578.0M | 597.0M | 599.0M |
| EBITDA | 2.67B | 1.59B | 2.25B | 2.27B | 2.48B | 2.03B |
| Interest expense | 347.0M | 367.0M | 0 | 0 | ||
| Income before tax | 1.71B | 605.0M | 1.67B | 1.69B | 1.88B | 1.44B |
| Income tax | 157.0M | 127.0M | 321.0M | 349.0M | 422.0M | 302.0M |
| Net income | 1.56B | 479.0M | 1.35B | 1.34B | 1.46B | 1.14B |
| Earnings per share, basic | 8.94 | 2.77 | 7.79 | 7.78 | 8.47 | 6.60 |
| Earnings per share, diluted | 8.88 | 2.76 | 7.79 | 7.78 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 878.0M | 762.0M | 194.0M | 61.0M | 91.0M | |
| Short-term investments | 406.0M | |||||
| Receivables | 1.03B | 1.04B | 1.31B | 1.17B | 1.18B | |
| Inventory | 1.07B | 965.0M | 857.0M | 873.0M | 813.0M | |
| Current assets | 3.86B | 3.25B | 2.52B | 2.23B | 2.19B | |
| Property, plant and equipment | 1.33B | 1.62B | 1.46B | |||
| Goodwill | 5.70B | 6.38B | 6.54B | 6.43B | 6.67B | |
| Total assets | 14.3B | 14.5B | 13.9B | 13.6B | 14.1B | |
| Accounts payable | 687.0M | 618.0M | 477.0M | 348.0M | 320.0M | |
| Current liabilities | 3.14B | 2.70B | 1.73B | 1.31B | 1.41B | |
| Long-term debt | 5.04B | 7.81B | 0 | |||
| Total debt | 5.04B | 8.01B | 0 | 95.0M | 112.0M | |
| Total liabilities | 9.24B | 11.5B | 2.28B | 1.85B | 2.02B | |
| Shareholders' equity | 5.05B | 2.96B | 11.7B | 11.7B | 12.1B | |
| Shares outstanding | 173.5M | 172.8M | 0 | 173.5M | 172.5M | 172.5M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash from operations | 369.0M | 1.19B | 1.92B | 1.68B | 2.20B | 2.03B |
| Capital spending | -379.0M | -380.0M | -290.0M | -251.0M | -277.0M | -271.0M |
| Free cash flow | -10.0M | 805.0M | 1.63B | 1.43B | 1.93B | 1.75B |
| Cash from investing | 2.80B | -380.0M | -230.0M | -253.0M | -278.0M | 228.0M |
| Cash from financing | -3.06B | -240.0M | -1.55B | -1.46B | -1.96B | -2.21B |
| Change in cash | 116.0M | 568.0M | 133.0M | -30.0M | -33.0M | 40.0M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 19, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 5, 2026 | Results | SEC |
| 4 · Change in ownership | Sep 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 18, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 5, 2026 | Results | SEC |
| 8-K · Current report | Aug 5, 2026 | Current report | SEC |
| 8-K · Current report | Jul 20, 2026 | Management or board change | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Jun 5, 2026 | Current report | SEC |
| SD · Specialized disclosure | May 29, 2026 | ESG report | SEC |
| 8-K · Current report | May 27, 2026 | Management or board change | SEC |
| 8-K · Current report | May 20, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | May 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 5, 2026 | Results | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 30, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| DEFA14A · Additional proxy material | Mar 27, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Mar 27, 2026 | Meeting notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Mar 24, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Mar 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 10-K · Annual report | Feb 27, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 26, 2026 | Results | SEC |
| 4 · Change in ownership | Feb 3, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jan 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Jan 5, 2026 | Insider trade | SEC |
| 8-K · Current report | Dec 16, 2025 | Current report | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Nov 18, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 13, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 6, 2025 | Results | SEC |
| 8-K · Current report | Oct 21, 2025 | Management or board change | SEC |
| 8-K · Current report | Sep 8, 2025 | Current report | SEC |
| 4 · Change in ownership | Sep 2, 2025 | Insider trade | SEC |
| 8-K · Current report | Sep 2, 2025 | Acquisition or disposal | SEC |
| 8-K · Current report | Aug 22, 2025 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 18, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 18, 2025 | Insider trade | SEC |
| 8-K · Current report | Aug 15, 2025 | Current report | SEC |
| 424B7 · Prospectus | Aug 14, 2025 | Offer document | SEC |
| 424B7 · Prospectus | Aug 13, 2025 | Offer document | SEC |
| FWP · Free writing prospectus | Aug 13, 2025 | Offer document | SEC |
| S-3ASR · Registration statement | Aug 13, 2025 | Offer document | SEC |
| 8-K · Current report | Aug 13, 2025 | Current report | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 13, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 7, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 7, 2025 | Results | SEC |
| 8-K · Current report | Jun 25, 2025 | Material contract | SEC |
| SD · Specialized disclosure | May 30, 2025 | ESG report | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | May 9, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 8, 2025 | Results | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 8-K · Current report | May 2, 2025 | Meeting outcome | SEC |
| ARS · Annual report to shareholders | Mar 21, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Mar 21, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Mar 21, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| IRANNOTICE | Feb 28, 2025 | Other filings | SEC |
| 10-K · Annual report | Feb 28, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 27, 2025 | Material contract | SEC |
| 8-K · Current report | Feb 27, 2025 | Results | SEC |
| 4 · Change in ownership | Feb 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2025 | Insider trade | SEC |
| EFFECT · Notice that a registration is effective | Dec 18, 2024 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Dec 11, 2024 | Offer document | SEC |
| 4/A · Change in ownership, amended | Dec 10, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2024 | Insider trade | SEC |
| EFFECT · Notice that a registration is effective | Dec 3, 2024 | Other filings | SEC |
| 424B3 · Prospectus | Dec 2, 2024 | Offer document | SEC |
| CORRESP · Letter to the SEC | Nov 26, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Nov 20, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Nov 19, 2024 | Other filings | SEC |
| S-4 · Registration statement | Nov 15, 2024 | Offer document | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 12, 2024 | Big-stake notice | SEC |
| IRANNOTICE | Nov 8, 2024 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 8, 2024 | Quarterly report | SEC |
| SC 13G · Big-stake notice | Nov 8, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Nov 7, 2024 | Results | SEC |
| 8-K · Current report | Nov 5, 2024 | Management or board change | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 4, 2024 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Oct 24, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Sep 26, 2024 | Current report | SEC |
| 4 · Change in ownership | Sep 4, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 14, 2024 | Insider trade | SEC |
| IRANNOTICE | Aug 9, 2024 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 9, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 8, 2024 | Results | SEC |
| 8-K · Current report | May 17, 2024 | Management or board change | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | May 10, 2024 | Quarterly report | SEC |
This page holds 200 of 264 filings. Open Filings
Cap table
Built by 6ix from Solventum Corporation’s releases
- Common shares
- 169,956,897
- Fully diluted
- 169,956,897
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 169,956,897 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 169,956,897 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Glenn Eisenberg Other companies: MiniMed Group, Inc. (Director · Since at least Mar 6, 2026); The Middleby Corporation (Independent Director · Since at least Mar 5, 2026); Lumexa Imaging Holdings, Inc. (Director · Since at least Dec 11, 2025); Fortrea Holdings Inc. (Executive Vice President, Director · Jun 9, 2023 – Jun 20, 2023 · Past); Perspecta Inc (Director · May 21, 2019 – May 6, 2021 · Past); US Ecology Inc (Director · Feb 2, 2018 – May 2, 2022 · Past); Sequenom Inc (EVP and Treasurer, Director · Sep 7, 2016 – Sep 7, 2016 · Past); Labcorp Holdings Inc. (Executive Vice President · Jun 16, 2014 – Mar 27, 2025 · Past); Alpha Natural Resources Inc (Director · May 17, 2006 – May 22, 2014 · Past); Family Dollar Stores Inc (Director · Jan 19, 2006 – Jul 6, 2015 · Past); Timken Company (the) (Ex VP Finance & Administration · Jan 10, 2006 – Feb 14, 2014 · Past) | Director · Since at least Apr 1, 2024 |
| Bryan Hanson Other companies: Walgreens Boots Alliance Inc (Director · Since at least Oct 27, 2022); Constellation Energy Corporation (Senior Executive Vice President and Chief Generation Officer · Since at least Feb 1, 2022); 3M Company (Group Pres & CEO Health Care · Sep 1, 2023 – Sep 1, 2023 · Past); Exelon Corporation (EVP & Chief Generation Officer · Sep 9, 2020 – Jan 28, 2022 · Past); Zimmer Biomet Holdings, Inc. (President and CEO, Director · Dec 19, 2017 – Mar 6, 2023 · Past); Medtronic plc. (EVP, President, MITG · Jan 26, 2015 – Dec 15, 2017 · Past); Covidien plc (Senior Vice President · May 3, 2013 – Jan 26, 2015 · Past) | Chief Executive Officer · Since at least Apr 1, 2024 |
| Carrie S. Cox Other companies: Organon & Co. (Executive Board Chair · Since at least Jun 2, 2021); Texas Instruments Incorporated (Director · Since at least Jul 28, 2015); Cartesian Therapeutics, Inc. (Director · Nov 20, 2019 – Jan 2, 2025 · Past); electroCore, Inc. (Director · Jun 21, 2018 – Jun 7, 2019 · Past); Cardinal Health, Inc. (Director · Nov 4, 2015 – Nov 9, 2022 · Past); Celgene Corporation (Director · Jul 1, 2015 – Nov 20, 2019 · Past) | Director · Since at least Apr 1, 2024 |
| Amy Wendell Other companies: Baxter International Inc. (Director · Since at least Feb 18, 2019); Hologic Inc (Director · Since at least Dec 14, 2016); Axogen, Inc. (Director · Since at least Sep 16, 2016); ChronoScale Corporation (Director · May 6, 2015 – Sep 14, 2017 · Past); Covidien plc (Senior Vice President · Jun 29, 2007 – Jan 26, 2015 · Past) | Director · Since at least Apr 1, 2024 |
| Carlos Albán Other companies: SpringWorks Therapeutics Inc (Director · Since at least Jul 14, 2022); AbbVie Inc. (Vice Chairman · Dec 7, 2012 – Nov 16, 2020 · Past); Abbott Laboratories (Senior Vice President · Oct 15, 2009 – Dec 1, 2012 · Past) | Director · Since at least Apr 1, 2024 |
| Darryl L. Wilson Other companies: Primerica, Inc. (Director · Since at least Feb 17, 2024); NextEra Energy, Inc. (Director · Since at least Feb 16, 2023); Eaton Corporation, PLC (Director · Since at least Apr 27, 2022) | Director · Since at least Apr 1, 2024 |
| John H. Weiland Other companies: Cardinal Health, Inc. (Director · Sep 1, 2019 – Nov 11, 2021 · Past); Celgene Corporation (Director · Feb 13, 2018 – Nov 20, 2019 · Past); West Pharmaceutical Services, Inc. (Director · Jun 30, 2015 – May 1, 2018 · Past) | Director · Since at least Apr 1, 2024 |
| Rachel Ellingson Other companies: BioLife Solutions, Inc. (Director · Since at least Apr 1, 2021); Zimmer Biomet Holdings, Inc. (Chief Administrative Officer · Jan 4, 2021 – Feb 20, 2025 · Past); St. Jude Medical Inc (VP, Global Communications · Aug 30, 2012 – Jan 4, 2017 · Past) | Chief Strategy & Corporate Development Officer · Since at least Nov 5, 2026 |
| Bernard A Harris Jr Other companies: U.S. Physical Therapy, Inc. (Director · Since at least May 16, 2022); RTX Corporation (Director · Since at least Apr 25, 2022) | Director · Since at least Apr 1, 2024 |
| Heather Knight Other companies: Waters Corporation (Director · Since at least Aug 14, 2024); Baxter International Inc. (EVP, Chief Operating Officer · Mar 1, 2023 – Mar 6, 2025 · Past) | Chief Commercial Officer · Since at least Oct 21, 2025 |
All 31 people
| Person | Seat |
|---|---|
| Shirley Edwards Other companies: Baker Hughes Company (Director · Since at least May 22, 2024); Appian Corporation (Director · Since at least Oct 2, 2023) | Director · Since at least Apr 12, 2024 |
| Susan D. DeVore Other companies: Elevance Health, Inc. (Director · Since at least Aug 3, 2021); Unum Group (Director · Since at least Feb 22, 2018) | Director · Since at least Apr 1, 2024 |
| Wayde McMillan Other companies: Hologic Inc (Director · Since at least Apr 4, 2025); Insulet Corporation (EVP, CFO · Feb 18, 2019 – Jul 3, 2023 · Past) | Chief Financial Officer · Since at least Apr 1, 2024 |
| Elizabeth A. Mily Other companies: Bristol-Myers Squibb Company (EVP, Strategy & BD · Mar 30, 2020 – Apr 1, 2023 · Past) | Director · Since at least Apr 1, 2024 |
| Kathy Weiler Other companies: Axogen, Inc. (Director · Since at least Aug 11, 2026) | Chief Transformation and Enterprise Services Officer · Since at least Nov 4, 2026 |
| Marcela Kirberger Other companies: Elanco Animal Health Incorporated (SEE REMARKS · Jun 22, 2021 – Mar 1, 2023 · Past) | Chief Corporate and Legal Affairs Officer and Corporate Secretary · Since at least Apr 1, 2024 |
| Tammy Gomez Other companies: Accendra Health, Inc. (EVP, CHRO · Jul 11, 2022 – Aug 15, 2023 · Past) | Chief Human Resources Officer · Since at least Apr 1, 2024 |
| Theresa E Reinseth Other companies: 3M Company (Sr Vice President & CAO · Since at least Aug 1, 2022) | Director · Mar 13, 2024 – Mar 13, 2024 · Past |
| Amy Landucci | Chief Information & Digital Officer · Since at least Apr 1, 2024 |
| Bernard A. Harris | Managing Partner, Versalius Ventures, Inc. · May 1, 2026 – Sep 3, 2026 · Past |
| Chris Barry | Executive Vice President · Apr 1, 2024 – May 13, 2025 · Past |
| Justin McGough | Director · Mar 13, 2024 – Mar 13, 2024 · Past |
| Karen J. May | Director · Since at least Apr 1, 2024 |
| Ken Tripp | Chief Supply Chain Officer · Since at least Nov 5, 2026 |
| Mary T Wilcox | Chief Accounting Officer · Since at least Apr 1, 2024 |
| Michael J Ottesen | Vice President, Director · Mar 13, 2024 – Mar 13, 2024 · Past |
| Mike Spears | Senior Vice President, Regulatory Affairs & Quality Assurance · Since at least Nov 4, 2026 |
| Neil Craig Zieselman | SVP, Controller & CAO · Since at least Aug 10, 2026 |
| Paul Harrington | Chief Supply Chain Officer · Since at least Apr 1, 2024 |
| Rodolfo Espinosa-Casaubon | Treasurer, Director · Mar 13, 2024 – Mar 13, 2024 · Past |
| Teresa K Crockett | President, Director · Mar 13, 2024 – Mar 13, 2024 · Past |
Log in to ask 6ix AI your own questions about Solventum Corporation.